Vanguard Global Advisers
GMED icon

Vanguard Global Advisers’s Globus Medical GMED Stock Holding History

Vanguard Global Advisers’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.8M Buy
48,136
+2,879
+6% +$245K ﹤0.01% 905
2026
Q1 		$3.9M Buy
+45,257
New +$4.06M ﹤0.01% 854

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Vanguard Global Advisers's GMED Position: Q2 2026 in Review

Vanguard Global Advisers increased its Globus Medical (GMED) stake by 6.4% in Q2 2026, buying an estimated $245K and bringing the position to 48,136 shares worth $3.8M. The position accounts for ﹤0.01% of the portfolio, ranked #905.

Vanguard Global Advisers first reported a position in GMED in Q1 2026 and has held it in 2 quarters since. The position peaked at $3.9M in Q1 2026. 586 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Vanguard Global Advisers held 48,136 shares of Globus Medical worth $3.8M as of Q2 2026.
  • Vanguard Global Advisers bought 2,879 Globus Medical shares in Q2 2026, an estimated $245K.
  • Globus Medical made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #905 holding.
  • Vanguard Global Advisers first reported a position in Globus Medical in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's Globus Medical position peaked at $3.9M in Q1 2026.
  • 586 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.